Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Lindskog

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
BMC Palliative Care|July 22, 2022
Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register studyMagnus Lindskog, Torbjörn Schultz, Peter Strang
Medical Oncology (Northwood, London, England)|January 31, 2014
Prognostic significance of serum albumin in patients with metastatic renal cell carcinomaMaria Stenman, Anna Laurell, Magnus Lindskog
European Journal of Cancer (Oxford, England : 1990)|May 11, 2015
Old age as risk indicator for poor end-of-life care quality - a population-based study of cancer deaths from the Swedish Register of Palliative CareMagnus Lindskog, Björn Tavelin, Staffan Lundström
Current Opinion in Supportive and Palliative Care|September 27, 2014
Glycaemic control in end-of-life careMagnus Lindskog, Lars Kärvestedt, Carl Johan Fürst
Studies in Health Technology and Informatics|August 22, 2015
Using a Participatory Action Research Design to Develop an Application Together with Young Adults with Spina BifidaHelene Lidström, Magnus Lindskog-Wallander, Eva Arnemo
Journal of Pain and Symptom Management|March 27, 2025
Bronchoscopic Intervention Reduces Dyspnea in Severely Symptomatic Patients With Central Malignant Airway ObstructionMalin Svensson, Andreas Palm, Nilla Westöö, et al.
BMC Medical Ethics|May 22, 2016
Heed or disregard a cancer patient's critical blogging? An experimental study of two different framing strategiesNiels Lynøe, Sara NattochDag, Magnus Lindskog, et al.
Journal of the National Cancer Institute|October 7, 2004
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastomaMagnus Lindskog, Christian Spenger, Jüri Jarvet, et al.
Oncology Reports|July 29, 2003
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenograftsFrida Ponthan, Magnus Lindskog, Nina Karnehed, et al.
BJUI Compass|January 1, 2026
Real-world drivers of treatment choices in synchronous metastatic renal cell carcinomaTarik Almdalal, Maja Fahlén, Ulrika Harmenberg, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
BMC Palliative Care|July 22, 2022
Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register studyMagnus Lindskog, Torbjörn Schultz, Peter Strang
Medical Oncology (Northwood, London, England)|January 31, 2014
Prognostic significance of serum albumin in patients with metastatic renal cell carcinomaMaria Stenman, Anna Laurell, Magnus Lindskog
European Journal of Cancer (Oxford, England : 1990)|May 11, 2015
Old age as risk indicator for poor end-of-life care quality - a population-based study of cancer deaths from the Swedish Register of Palliative CareMagnus Lindskog, Björn Tavelin, Staffan Lundström
Current Opinion in Supportive and Palliative Care|September 27, 2014
Glycaemic control in end-of-life careMagnus Lindskog, Lars Kärvestedt, Carl Johan Fürst
Studies in Health Technology and Informatics|August 22, 2015
Using a Participatory Action Research Design to Develop an Application Together with Young Adults with Spina BifidaHelene Lidström, Magnus Lindskog-Wallander, Eva Arnemo
Journal of Pain and Symptom Management|March 27, 2025
Bronchoscopic Intervention Reduces Dyspnea in Severely Symptomatic Patients With Central Malignant Airway ObstructionMalin Svensson, Andreas Palm, Nilla Westöö, et al.
BMC Medical Ethics|May 22, 2016
Heed or disregard a cancer patient's critical blogging? An experimental study of two different framing strategiesNiels Lynøe, Sara NattochDag, Magnus Lindskog, et al.
Journal of the National Cancer Institute|October 7, 2004
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastomaMagnus Lindskog, Christian Spenger, Jüri Jarvet, et al.
Oncology Reports|July 29, 2003
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenograftsFrida Ponthan, Magnus Lindskog, Nina Karnehed, et al.
BJUI Compass|January 1, 2026
Real-world drivers of treatment choices in synchronous metastatic renal cell carcinomaTarik Almdalal, Maja Fahlén, Ulrika Harmenberg, et al.
Pageof 5